V. Karschin

Ticagrelor or Prasugrel for Platelet Inhibition in Acute Coronary Syndrome Patients: The ISAR-REACT 5 Trial.

H. Schunkert, A. Kastrati, D. Angiolillo, 2020, Journal of the American College of Cardiology.

Immature platelet fraction is a strong predictor of adverse cardiovascular events in patients with acute coronary syndrome. Results of the ISAR-REACT 5 reticulated platelet substudy

H. Schunkert, A. Kastrati, K. Mayer, 2020 .

ADP-induced platelet aggregation in patients with acute coronary syndrome treated with prasugrel or ticagrelor. Results of the ISAR REACT 5 platelet aggregation substudy

H. Schunkert, A. Kastrati, K. Mayer, 2020 .